MAIA Biotechnology Inc. (NYSE MKT:MAIA) — Stock Price
MAIA Biotechnology Inc. (NYSE MKT:MAIA) is currently trading at $1.28 USD, up 0.00% today. Over the past 52 weeks, shares have ranged between $0.87 and $2.95. This page tracks MAIA Biotechnology Inc.'s live share price on the NYSE MKT exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see MAIA Biotechnology Inc. cash conversion from operations.
MAIA Biotechnology Inc. (MAIA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks MAIA Biotechnology Inc.'s daily closing share price and trading volume on the NYSE MKT exchange over the past year, giving a clear view of recent price momentum and liquidity.
MAIA Biotechnology Inc. Income Statement — Revenue, Profit & Earnings by Year
MAIA Biotechnology Inc.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Research & Development | $14.55 Billion | $10.01 Million | $11.11 Million | $8.93 Million | $3.45 Million |
| SG&A | $9.72 Billion | $6.95 Million | $9.07 Million | $6.14 Million | $4.29 Million |
| Total Operating Expenses | $24.27 Million | $16.96 Million | $20.18 Million | $16.18 Million | $7.79 Million |
| Operating Income | $-24.27 Million | $-16.96 Million | $-20.18 Million | $-16.18 Million | $-7.79 Million |
| EBITDA | $-24.27 Million | $-23.25 Million | $-19.77 Million | $-15.76 Million | $-11.75 Million |
| EBIT | — | $-23.25 Million | $-20.18 Million | $-16.18 Million | $-15.53 Million |
| Interest Expense | $0.00 | $57.00 | $6.86K | $6.97K | $827.54K |
| Income Before Tax | $-22.40 Million | $-23.25 Million | $-19.77 Million | $-15.77 Million | $-12.58 Million |
| Income Tax Expense | — | $-79.95K | $-176.72K | $36.69K | $707.53K |
| Net Income | $-22.40 Million | $-23.25 Million | $-19.77 Million | $-15.77 Million | $-12.50 Million |
MAIA Biotechnology Inc. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes MAIA Biotechnology Inc.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $9.70 Million | $10.16 Million | $7.57 Million | $12.02 Million | $11.33 Million |
| Total Current Assets | $9.70 Million | $10.15 Million | $7.56 Million | $11.81 Million | $10.67 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | — | $77.35K | $144.68K | $302.79K | $43.67K |
| Inventory | — | — | — | — | $-43.67K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $7.33 Million | $6.52 Million | $7.09 Million | $3.51 Million | $2.15 Million |
| Total Current Liabilities | $5.84 Million | $3.83 Million | $4.94 Million | $3.27 Million | $2.15 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-8.66 Billion | $-9.60 Million | $-7.15 Million | $-10.95 Million | $-10.57 Million |
| Total Stockholder Equity | $2.38 Million | $3.63 Million | $477.51K | $8.51 Million | $9.18 Million |
| Retained Earnings | $-109.63 Million | $-87.23 Million | $-63.98 Million | $-44.21 Million | $-28.44 Million |
MAIA Biotechnology Inc. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how MAIA Biotechnology Inc. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-18.84 Million | $-15.70 Million | $-13.07 Million | $-12.10 Million | $-4.12 Million |
| Capital Expenditures | $0.00 | $0.00 | $4.00 | $0.00 | $0.00 |
| Free Cash Flow | $-18.84 Million | $-15.70 Million | $-13.07 Million | $-12.10 Million | $-4.12 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | $17.91 Million | $18.18 Million | $9.27 Million | $12.48 Million | $14.03 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $2.63 Million | $1.91 Million | $3.09 Million | $2.32 Million | $2.72 Million |
| Depreciation | — | — | — | — | — |
| Change in Cash | $-943.27K | $2.45 Million | $-3.80 Million | $376.63K | $9.91 Million |
MAIA Biotechnology Inc. Earnings History — EPS Actual vs. Analyst Estimates
Track MAIA Biotechnology Inc.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 04, 2026 | -0.14 | -0.18 | +22.22% |
| Mar 23, 2026 | -0.14 | -0.13 | -5.23% |
| Nov 04, 2025 | -0.27 | -0.19 | -42.11% |
| Aug 11, 2025 | -0.18 | -0.25 | +28.00% |
| May 09, 2025 | -0.16 | -0.18 | +11.11% |
| Mar 24, 2025 | -0.32 | -0.35 | +8.57% |
| Nov 06, 2024 | -0.36 | -0.47 | +24.47% |
| Aug 19, 2024 | -0.50 | -0.42 | -20.48% |